You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for Patent: 7,314,874


✉ Email this page to a colleague

« Back to Dashboard


Title:Benzamides and related inhibitors of factor Xa
Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.
Inventor(s): Zhu; Bing-Yan (Palo Alto, CA), Zhang; Penglie (Foster City, CA), Huang; Wenrong (Cupertino, CA), Scarborough, deceased; Robert M. (Half Moon Bay, CA)
Assignee: Millennium Pharmaceuticals, Inc. (Cambrdige, MA)
Filing Date:Sep 15, 2004
Application Number:10/942,733
Claims:1. A compound having the following structure: ##STR00596## wherein: R.sup.1a is H or F; R.sup.1d1 is H or --OMe; A-Q is a member selected from the group consisting of: ##STR00597## or a pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives thereof.

2. A compound of claim 1, wherein R.sup.1a is H.

3. A compound of claim 1, wherein R.sup.1a is F.

4. A compound of claim 1, wherein R.sup.1d1 is H.

5. A compound of claim 1, wherein R.sup.1d1 is --OMe.

6. A compound of claim 1 selected from the group consisting of: ##STR00598## or a pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives thereof.

7. A pharmaceutical composition for preventing or treating a condition in a mammal characterized by undesired thrombosis comprising a phannaceutically acceptable carrier and a pharmaceutically effective amount of a compound of claim 1.

8. A method for preventing or treating a condition in a mammal characterized by undesired thrombosis comprising administering to said mammal a therapeutically effective amount of a compound of claim 1.

9. The method of claim 8, wherein the condition is selected from the group consisting of: acute coronary syndrome, myocardial infarction, unstable angina, refractory angina, occlusive coronary thrombus occurring post-thrombolytic therapy or post-coronary angioplasty, a thrombotically mediated cerebrovascular syndrome, embolic stroke, thrombotic stroke, transient ischemic attacks, venous thrombosis, deep venous thrombosis, pulmonary embolus, coagulopathy, disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, thromboangiitis obliterans, thrombotic disease associated with heparin-induced thrombocytopenia, thrombotic complications associated with extracorporeal circulation, thrombotic complications associated with instrumentation, and thrombotic complications associated with the fitting of prosthetic devices.

10. A method for inhibiting the coagulation of a biological sample, comprising the step of administering a compound of claim 1.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.